Bouleau verruqueux
Food supplement declared in France, declaration No 2018-2-43, decision dated 1 February 2018
Bouleau verruqueux (Melilotus) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Melilotus
- Food business operator placing the product on the market
- GAEC MELILOTUS
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Compte-gouttes
- Daily dose
- 5 à 15 gouttes
- Directions for use
- 5 à 15 gouttes diluées dans un peu d'eau à prendre en dehors des repas
- Not recommended for (according to the manufacturer)
- Allergie aux dérivés salicylés
Declaration 286043, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Betula pendula Roth: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Betula pendula Roth | Bourgeon | Macérât hydroglycériné | 0.1 g |
Other active ingredients
| Name | Per day |
|---|---|
| miel d’acacia | not declared |
Other ingredients
Alcool éthylique, eau
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé aux personnes souffrant d'allergie aux dérivés salicylés
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Betula pendula Roth
Read the warning, when it applies and the studies cited
Birch
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : Melilotus
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.